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ABSTRACT: This paper describes a procedure for the synthesis and application of a citalopram-derived affinity 
resin in purifying the 5HT-reuptake system from human blood platelets. A two-step scheme has been 
developed for partial purification, based on wheat germ agglutinin-lectin (WGA) affinity and citalopram 
affinity chromatographies. Upon solubilization of the carrier with 1% digitonin, a 50-70-fold increase in 
specific [3H]imipramine binding activity with a 70% recovery could be accomplished through WGA-lectin 
chromatography. The WGA pool was then subjected to affinity chromatography on citalopram-agarose. 
At least 90% of the binding capacity adsorbed to the column. Specific elution using 10 pM citalopram 
resulted in a 22% recovery of binding activity. A 10000-fold overall purification was obtained by using 
this two-step procedure. Analysis of the fractions on SDS-PAGE after lZ5I labeling revealed specific elution 
of 78- and 55-kDa proteins concomitant with the appearance of [3H]imipramine binding activity. The 
pharmacological profile of the partially purified reuptake system correlated well with that derived from 
the crude membrane-bound reuptake system, suggesting a copurification of the 5 H T  binding activity and 
13H] imipramine binding activity. 
x e  5HT-reuptake system has been well documented, during 
the past decades, by both radioligand binding and 5HT- 
transport studies (Davis, 1984). Substantial evidence has been 
furnished supporting the concept that the 5HT-reuptake 
system involves closely interacting sites, a carrier site and a 
regulatory imipramine binding site (IBS).' Binding of re- 
uptake inhibitors to the regulatory site strongly inhibits 5HT 
reuptake. The structural relationship between the transport 
and regulatory sites is unclear (Humphreys et al., 1988; Biessen 
et al., 1988; Reith et al., 1984; Mellerup et al., 1983; Sette 
et al., 1983). Despite the fact that 5HT reuptake appears to 
be more or less clarified on a macroscopic level, the molecular 
basis of transport and its regulation are only poorly understood. 
The molecular masses of the functional imipramine and pa- 
roxetine binding site were estimated by using radiation inac- 
tivation studies to be 86 and 67 kDa, respectively (Mellerup 
et al., 1984). By contrast, photoaffinity labeling of the IBS 
using [3H]-2-nitroimipramine and [3H]-2-azidoimipramine 
revealed incorporation of the photoaffinity label in a 30-35- 
kDa protein (Wennogle et al., 1985; Rotman & Pridluda, 
1982). Whether the labeling was specific has not been con- 
vincingly demonstrated. 
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Organization for the Advancement of Pure Resarch (NWO). 
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Abbreviations: AMC, (aminomethy1)citalopram; BSA, bovine se- 
rum albumin; CBB, Coomassie Brilliant Blue; Con-A, concanavalin A; 
DMSO, dimethyl sulfoxide; DTT, dithiothreitol; EDTA, (ethylenedi- 
nitri1o)tetraacetic acid; El, electron impact; EG, ethylene glycol; IBS, 
imipramine binding site; KAc, potassium acetate; KP,, potassium phos- 
phate; NaSCN, sodium thiocyanate; PAA, polyacrylamide; PEG, poly- 
(ethylene glycol); PMSF, phenylmethanesulfonyl fluoride; Tris, tris(hy- 
droxymethy1)aminomethane; WGA, wheat germ agglutinin. 
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Solubilization of the 5HT-reuptake system from both 
thrombocytes and brain tissue with digitonin, CHAPS, or 
lysolecithin to yield a preparation retaining most of the 
characteristics of the crude reuptake system has been reported 
by various research groups (Talvanheimo & Rudnick, 1980; 
Habert et al., 1986; Cesura et al., 1983; Rehavi et al., 1982). 
I n  view of its minute density and the high affinity of most 
selective reuptake inhibitors for the transport system, affinity 
chromatography appeared to be the method of choice in iso- 
lating the system. In  this paper we present the synthesis of 
a citalopram-derived affinity resin and a two-step purification 
scheme using WGA-lectin and citalopram affinity chroma- 
tographies which allow a 10 000-fold purification. The 
pharmacological profiles of the purified protein and the crude 
membrane-bound or solubilized reuptake system are essentially 
the same, suggesting a copurification of the 5HT and imipr- 
amine binding activity. 
METHODS 
Tissue Preparation. The platelet membranes were prepared 
by a modification of the procedure of Mellerup et al. (1983) 
as previously reported (Biessen et al., 1988). After preparation 
of the platelet membranes, the tissue was suspended in solu- 
bilization buffer (250 mM NaSCN, 50 mM Tris-HC1, 5 mM 
KCI, 1 mM EDTA, 2 mM MgCl,, 0.3 mM DTT, 0.1 mM 
PMSF, pH 7.5) at a protein concentration of 15 mg/mL and 
the membranes were solubilized by incubation with an equal 
volume of 2% digitonin in solubilization buffer for 60 min at 
4 OC under mild agitation. After centrifugation (60 min at 
IOOOOOg), the supernatant was decanted and stored in liquid 
nitrogen at a protein concentration of about 5-7 mg/mL. 
['HI Imipramine Binding Assay. Radioligand-binding as- 
says were performed according to the method previously re- 
ported (Biessen et al., 1988). Displacement binding studies 
were performed at a fixed concentration of 4 nM ['Hlimi- 
pramine in the presence of unlabeled displacer, at 10 con- 
centrations (or 7 for the partially purified preparation) ranging 
from 0.1 nM to 100 pM. Following incubation with [3H]im- 
ipramine, the reuptake system was rapidly precipitated by 
adding 100 pL of 0.3% bovine y-globulin immediately followed 
by 200 pL of 30% PEG 6000. After the precipitate was 
vigorously shaken, it was filtered on a Millipore manifold under 
vacuum over 15-mm Schleicher & Schuell glass fiber filters 
that were preincubated in buffer containing 0.3% poly(ethy1ene 
imine) to reduce nonspecific binding. Filters were washed with 
2 X 2 mL ice-cold buffer. Radioactivity was measured after 
incubation overnight in 4 mL of Packard emulsifier scintillator 
299 in a Beckman scintillation counter at a counting efficiency 
of about 50%. 
Prepurification of the Solubilizate with WGA-Lectin Se- 
pharose. All purification procedures were carried out at 4 OC. 
Solubilizate (10 mL, containing about 75 mg of protein) was 
incubated batchwise for 18 h with a 15 mL bed volume of 
WGA lectin Sepharose, preequilibrated with 50 mL of WGA 
buffer (assay buffer, containing 0.1 % digitonin) under slow 
rotation. The gel slurry was poured into a column (25 X 2 
cm) and washed with 100 mL of WGA buffer at a flow of 1.0 
mL/min. Then the column was eluted by using a linear 50-mL 
gradient of N-acetylglucosamine (0-200 mM) in WGA buffer 
at a flow of 0.15 mL/min. Fractions of 10 mL for the wash 
step and 5 mL for the elution step were collected, and aliquots 
of each fraction were taken to assay for ['Hlimipramine 
binding and to monitor the 
Affinity Chromatography Using AMC-Affi-Gel. For 
preparative purposes, the WGA pool was mixed, directly after 
pooling, with a 10 mL bed volume of AMC-Affi-Gel, pree- 
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quilibrated with 50 mL of WGA buffer, and rotated overnight 
at 4 OC. The gel slurry was poured into a column (30 X 2.5 
cm) and subjected to a three-step washing procedure: 25 mL 
of buffer, containing 10 mM KPi (pH 7.5), 100 mM NaCl, 
2 mM MgCl,, 1 mM EDTA, 0.1 mM PMSF, 0.3 mM DTT, 
0.02% NaN,, and 0.1% digitonin (AMC buffer), followed by 
35 mL of AMC buffer containing 20% EG and 20 mL of 
AMC buffer lacking NaCl at a flow of 0.8 mL/min. Fractions 
of 8 mL were collected. Then the column was eluted with 
AMC buffer lacking NaCl but containing 10 pM citalopram 
at a flow of 6 mL/h. Fractions of 10 mL were collected during 
the wash steps, and 5-mL fractions were collected during the 
elution step. The fractions of the elution phase were dialyzed 
against 2 L of buffer containing 10 mM KPi, 100 mM NaCI, 
2 mM MgCl,, 1 mM EDTA, 0.3 mM DTT, and 0.1 mM 
PMSF, overnight at 4 OC, followed by two dialysis steps of 
4 h against 2 L of this buffer. Finally, aliquots were taken 
to assay for ['Hlimipramine binding. The degree of purifi- 
cation was monitored by using SDS-PAGE after lZ5I labeling. 
1 - [ 3- 
(Dimethylamino)propyl] - 1 -(p-fluorophenyl)-5-(amino- 
methy1)phthalan (AMC) was synthesized by reduction of 
citalopram. In short, 500 mg of citalopram-HBr, dissolved 
in 50 mL of H20 ,  was extracted with 3 X 100 mL of CHC1, 
at pH 13 (NaOH). The chloroform fractions were pooled, 
dried over MgS04, and evaporated. Then the free base was 
dissolved in 3 mL of dry ether, and the solution was added 
dropwise to 100 mg of LiAIH4 in 4 mL of dry ether and 
refluxed for 3 h. After reacting, the mixture was put on ice 
and the LiAlH4 was granulated by the addition of 100 pL of 
H,O, 100 r L  of 4 N NaOH, and 300 pL of H20 .  The 
precipitate was filtered, and the ether was evaporated. The 
product was crystallized from acetonitrile as a HCl salt and 
dried under vacuum to give 390 mg of product (78%): mp 
186-190 OC; mass spectrometry (EI) m / e  328 (M+), 283,242, 
84; IR (KBr) 3415,2950,2860,1606, 1507, 1465, 1230, 1168, 
1040,1023, and 839 cm-I; 'H NMR (DzO + DCl) (60 MHz) 
b 6.9-7.6 (7 H, m) (the former indicates the number of protons 
observed and the latter indicates the peak multiplicity), 5.3 
(2 H, s), 4.08 (2 H, s), 3.3 (2 H, t), 3.08 (2 H, t), 2.90 (6 H, 
s), 2.29 (2 H, t), 1.85 (2 H, 9). A single spot on TLC, using 
EtOAc/EtOH ( l : l ) ,  was observed. 
Preparation of AMC-Affi-Gel. Coupling of the citalopram 
derivative was achieved as follows. AMC.2HCI (700 mg) was 
dissolved in 25% DMSO and 25% 1,Cdioxane in KP, buffer 
(50 mM, pH 7.0). The solution was added to 15 mL of 
preswollen NHS-activated Sepharose (Affi- lo), and the 
mixture was rotated at room temperature for 4 h. Next, the 
gel slurry was incubated overnight at 4 "C under constant 
agitation, and the slurry was washed batchwise with a diox- 
ane /H20 mixture decreasing from 50% 1,4-dioxane to pure 
water. The unreacted, free NHS groups were quenched by 
incubation for 2 h with 1 M ethanolamine at room tempera- 
ture. Finally, the gel was washed thoroughly with 500 pL of 
SDS, 250 mL of water, 25%, 50%, 75%, 50%, and 25% ethanol 
and water, and finally 1 L 0.1 M KAc buffer (pH 4.0) to 
remove all free ligand. Even with this extensive washing 
procedure, some batches of AMC-Affi-gel still contained 
sufficiently high amounts of free AMC to prevent adsorption 
of binding activity to the AMC-Affi-Gel the first time that 
the gel was used after synthesis. 
Iodination with Chloramine T. Prior to gel electrophoresis, 
the affinity-purified samples were iodinated with Na1251 by 
using Chloramine T. In short, a 50-pL sample was reacted 
with 5 pL of NaIZSI (100 pCi) for 1 min at room temperature 
Synthesis of (Aminomethy1)citalopram (AMC).  
Hydroxytryptophan-Reuptake System from Human Platelets Biochemistry, Vol. 29, No. 13, 1990 3351 
0 
0 0 2  O L  0 6  0 8  1 12  1L 1 6  1 8  2 
conc Im%l 
FIGURE 1 : Effect of digitonin level on the solubilization yield and 
efficacy. Platelet membranes were incubated for 60 min at 4 "C with 
varying concentration of digitonin (0-2%) in solubilization buffer. 
After incubation, the samples were centrifuged at IOOOOOg for 60 min 
and the supernatant was separated from the pellets. Both supernatant 
(0) and pellets (O), resuspended in the original volume of solubilization 
buffer, were assayed for binding activity, in triplicate. Protein content 
of the supernatant fractions was determined according to the method 
of Bradford (A). 
in the presence of 5 pL of chloramine T (1 mg/mL in HzO). 
The iodination was terminated by addition of 5 pL of sodium 
metabisulfite ( 1  mg/mL in H,O). Following treatment with 
65 pL of denaturation buffer at room temperature for 30 min, 
50-pL samples were subjected to gel electrophoresis on 
10-12.5% polyacrylamide gel according to the method of 
Laemmli (1970). Low molecular weight markers (Pharmacia) 
at concentrations of 50 ng of protein/mL each, and two BSA 
standards, at concentrations ranging from 50 to 5 ng/mL, were 
analogously iodinated and subjected to SDS-PAGE to cali- 
brate the gel and to quantify the intensity of the visualized 
proteins. After running, the gel was washed for 1 h with 50% 
MeOH and dried under vacuum at 65 'C, and '251-labeled 
proteins were visualized by using autoradiography on Ko- 
dak-X-Omat for 1-3 days at  -70 "C. 
Data Calculation and Statistical Analysis. Saturation curve 
data were subjected to a nonlinear regression program 
(Graph-Pad) fitting saturation according to a single-site 
binding model to evaluate Kd and B,,, values. Displacement 
binding data were analyzed according to a single-site dis- 
placement binding model using a computerized nonlinear 
fitting program (Graph-Pad) to calculate the Ki and the ap- 
parent Hill coefficient. 
Materials. All chemicals were of reagent grade. The re- 
uptake inhibitors were generous gifts from their respective 
firms: imipramine and clomipramine from Ciba-Geigy Lab 
(Basel, Switzerland); citalopram from Lundbeck (Copenhagen, 
Denmark); zimelidine from Astra (Sweden); ORG 6582 from 
Organon (Oss, Holland); and femoxetin from Ferrosan 
(Denmark). Affi-Gel 10 was purchased from Bio-Rad 
(Richmond, CA) and digitonin from Fluka (Buchs, Switzer- 
land). [3H] Imipramine was purchased from New England 
Nuclear (Boston, MA; 52.6 and 45.3 Ci/mmol). Outdated 
platelet-rich plasma was kindly supplied by the Bloodbank, 
Groningen, The Netherlands. 
RESULTS 
Solubilization of the IBS. The IBS can be solubilized with 
digitonin. The summed activities of supernatant and the pellet 
directly reveal that digitonin can be used without loss of total 
activity at concentrations up to 1% digitonin (Figure 1).  
Protein is extracted from the membranes, even at 0% digitonin, 
possibly owing to the chaotropic action of sodium thiocyanate. 
Protein extraction leveled off at 1% digitonin. The solubili- 
zation yield increases at digitonin concentrations higher than 
Table I: Inhibition Constants for Various Reuptake Inhibitorsand- 
5HT' 
displacer DK; (nM f SD) 
partially 
platelet purified 










5.60 f 0.1 
7.90 f 0.2 
7.90 f 0.26 
8.30 f 0.3 
6.25 f 0.04 
6.3 f 0.17 
7.8 f 0.05 
8.2 f 0.35 
6.33 f 0.16 
5.77 0.08 
8.02 f 0.08 
8.09 f 0.07 ND 
7.84 f 0.07 
5.91 f 0.04 
6.12 f 0.04 ND 
7.74 f 0.07 
8.18 f 0.11 
6.36 f 0.07 ND 
5.09 f 0.23 
8.70 f 0.17 
8.49 f 0.06 
6.12 f 0.23 
7.77 f 0.18 
8.74 f 0.15 
Competition experiments were performed, in triplicate, at a fixed 
ligand concentration of approximately 4 nM [)H]imipramine for 7 
displacer concentrations, in the case of studies on a partially purified 
5HT-reuptake system, and for 10 displacer concentrations, in the case 
of solubilizate and crude membranes. pKi values were calculated from 
inhibition curve data by using a computerized nonlinear fitting proce- 
dure (Graph-Pad). ND indicates not determined. The correlation 
coefficients were 0.982 and 0.972 for partially purified vs crude and 
partially purified vs solubilized tissue, respectively. 
0 
B 
FIGURE 2: Chemical structure of the (aminomethy1)citalopram affinity 
resin (AMC-Affi-Gel, A). (Aminomethy1)citalopram was synthesized 
by reduction of citalopram (B). The affinity resin was synthesized 
by coupling of (aminomethy1)citalopram (C) to a N-hydroxy- 
succinimidyl-activated affinity resin as detailed under Materials and 
Methods. 
0.2% and is optimal at  1% digitonin. Under these optimal 
conditions, the solubilization yield is 6 2  f 4% (414 f 40 
fmol/mg of protein). Solubilization does not significantly 
affect the dissociation constant for imipramine; it was 2.47 
f 0.34 and 1.84 f 0.4 nM for solubilizate and crude platelet 
membranes, respectively. [3H]Imipramine binding kinetics 
on the solubilizate were in close agreement with the data on 
the crude membrane-bound system. The pharmacological 
binding profile of the solubilized IBS essentially matched that 
of the crude membrane-bound receptor (Table I; r = 0.987). 
Testing of the Citalopram-Derived Affinity Resin. AMC- 
Affi-Gel (Figure 2A) was selected from a series of 15 affinity 
resins based on structural analogues of imipramine, citalopram, 
and serotonin. About 5.3 pmol of AMC/g of wet resin was 
incorporated as determined by the extinction of hydrolyzed 
AMC-Affi-Gel at  260 nm. Preliminary studies showed that 
AMC-Affi-Gel adsorbed most of the binding activity (270%) 
and that the adsorbed binding activity could be recovered by 
specific elution with 10 pM citalopram. Preincubation of the 
solubilizate with 1 pM citalopram prior to chromatography 
largely prevented retention of binding activity, thus establishing 
the specific nature of adsorption of the binding activity to the 
column. In the case of preblocking, 50 f 15% of the binding 
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Volume lmll 
FIGURE 3: Elution profile of the WGA-Sephamw chromat raphy 
ipramine binding activity. was incubated overnight at 4 'C with IO 
mL of WGA-lain Sephamsr After packing, the column was washed 
with WGA buffer, followed by elution with a 0-200 mM linear 
gradient of N-acetylglumsamine in WGA buffer started at the arrow. 
The last fraction is 200 mM in N-acetylglumsamine. Fractions were 
monitored for ['Hlimipramine binding activity (0). Protein content 
was estimated by measuring the .E2% (0). For details, see Materials 
and Methods. 
activity eluted from the column in the flow-through and the 
first wash step, relative to only 7 f 5% in a control preparation 
which was not preblwked with citalopram (n = 2). Subse- 
quent specific elution with IO p M  citalopram resulted in de- 
sorption of approximately 49 f 15% (n  =2) of the applied 
binding activity for the control experiment, but only 4% in the 
case of preblwking with citalopram. 
Purification. In  a typical purification procedure, 10 mL 
of solubilizate, containing approximately 25 pmol of binding 
capacity, was subjected to a prepurification step on WGA- 
Sepharose to reduce the digitonin level and to eliminate some 
proteins or phospholipids that might interfere with the affinity 
chromatography step. As demonstrated in Figure 3, most of 
the protein eluted from the column in the flow-through, 
whereas more than 88 f 4% (n  = 8) of the binding capacity 
was retained. Elution of the column with an N-acetyl- 
glucosamine gradient resulted in 70 * 6% (n = 8) recovery 
of binding activity. SDS-PAGE analysis of the eluted frac- 
tions confirmed the large purification factor realized by this 
step; it was estimated to be 50-70-fold, on the basis of both 
the Em profile and scanning of the PAA gels. The WGA pool 
was directly incubated with AMC-Affi-Gel. A column was 
packed and washed by using the preparative procedure given 
under Methods. Directly following the washing steps, binding 
activity was eluted by using IO p M  citalopram. Figure 4 shows 
an elution profile of a typical experiment. Almost all the 
binding activity of the prepurified solubilizate is retained by 
the affinity column (91 f 2%. n 4). Binding activity can 
be recovered in part (22 f 4%) upon elution with IO p M  
citalopram. Analysis of the citalopram-eluted fractions on 
SDS-PAGE after labeling of the proteins with NaiZI revealed 
the appearance of 78- and 55-kDa proteins concomitantly with 
recovery of binding activity (Figure 5). The 78-kDa region 
appears to contain two bands; the lower of the two correlates 
with the presence of imipramine binding activity. The purity 
of the preparation was estimated lo be 5-10% on the basis of 
SDS-PAGE analysis. 
The pharmacological profile of the partially purified 
transporter was examined by using displacement binding 
studies of six typical reuptake inhibitors. Kl values of these 
compounds were comparable with values obtained by using 
crude platelet membranes. r = 0.982, or solubilizate, r = 0.972 
(Table I), suggesting a purification of the intact 5HT trans- 
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FIGURE 4 Chromatography of prepurified solubilizate on a citalb 
pramderived affinity rain (AMC-Affi-Gel). Typically. 30-40 mL 
of WGA-Sepharose-prified solubilizate. containing 15-20 pmol of 
binding activity. was incubated overnight at 4 OC with a I 5  mL bed 
volume of AMC-Alf-Gel. After packing of the gel slurry, the column 
was subjected to the following washing procedure: ( I )  KP, (arrow 
I ); (2) KPi + 20% ethylene glycol (arrow 2); (3)  KPi - NaCl (arrow 
3). Receptor activity was specifically eluted with IO rM citalopram 
in buffer 3 (arrow 4). Fractions were dial@ thoroughly and assayed 
for binding activity. Complete details are given under Materials and 
Methods. 
1L 94 kD 
m6*Ic 
43 kD a 
* 30 kD 
1 2  3 4 5  
FIGURE 5: SDS-PAGE analysis of the citalopram-eluted fractions 
fmm a single AMC chromatography, containing (lane 2) and lacking 
['Hlimipramine binding activity (lane I ) .  The sample used for lane 
2 was the fraction at 122 mL in Figure 4, and the fraction used for 
lane I was the small peak eluting at I12 mL in Figure 4. To quantify 
the intensity ofthe specifically eluted proteins. two "'1-labeled BSA 
standards, containing 0.2 and I n of protein/sample, were applied 
in lanes 3 and 4, respectively. ' 'I-labeled low molecular wei h t  
markers were applied in lane 5. Proteins were iodinated with NaA'I 
as described under Materials and Methods. 
porter. Only the affinity of serotonin, the substrate, was 
slightly reduced as compared to the value obtained by using 
solubilizate or crude platelet membranes (Ki  = 8.1 p M  for the 
partially purified preparation vs 1.7 and 2.5 pM for the sol- 
ubilizate and crude membranes, respectively). 
DISCUSSION 
Solubilization of an active 5HT-reuptake system using di- 
gitonin, CHAPS, or lysolecithin has been reported by several 
research groups (Habert et al., 1986; Cesura et al., 1983: 
Hydroxytryptophan-Reuptake System from Human Platelets 
Rehavi et al., 1982). Digitonin at a concentration of 1% results 
in the solubilization of at least 60% of the 5HT-reuptake 
system. Sodium thiocyanate stabilizes the complex during the 
solubilization relative to NaCl and slightly improves the 
solubilization yield, possibly by a chaotropic effect. The 
binding characteristics of the solubilized reuptake system 
closely resemble those from the original membrane-bound 
system. 
A series of 15 affinity resins, varying from each other in 
ligand type (imipramine, citalopram, and serotonin deriva- 
tives), ligand orientation, spacer length (ranging from 5 to 20 
A), and covalent coupling (amine, amide, ether, ester bond), 
were synthesized. The serotonin-derived affinity resins dis- 
played only moderate affinity for the reuptake system, leading 
to desorption of adsorbed proteins during the wash steps. A 
modest retention of binding activity was observed on chro- 
matography over a 2-aminoimipramine-derived affinity resin. 
Affinity resins based on 10-hydroxyimipramine and 3- 
carboxylimipramine performed badly. Desipramine, immo- 
bilized via the aminomethyl group of the 5-(y-methylamino- 
propyl) side chain, was capable of binding the SHT-reuptake 
system. However, once adsorbed, the binding activity could 
not be recovered even under the rather stringent condition of 
low pH. Generally, the citalopram-derived resins showed 
selective retention of binding activity. In view of the moderate 
affinity of AMC, Ki = 460 nM, this may appear surprising. 
However, the low affinity of AMC as compared with citalo- 
pram might reflect a charge rather than a steric effect. The 
Ki value of the derivatized citalopram containing an amide 
bond at the 5-position of the phthalan moiety was almost 50 
times lower than the Ki value of AMC, indicating that the 
positively charged atom at the 5-position has a deleterious 
effect on the affinity for the IBS. Of the citalopram-derived 
resins tested, AMC-Affi-Gel 10 appeared to be the most en- 
couraging. It exhibited biospecific retention of the 5HT-re- 
uptake system which could be inhibited by blocking of the 
transporter with citalopram. 
A number of chromatographic techniques, including hy- 
drophobic interaction chromatography, chromatofocusing, and 
dye, lectin, and heparin chromatographies, were screened. 
WGA chromatography offered the most promising results, 
yielding a highly specific purification, combined with a high 
recovery and reproducability. The binding of the transporter 
to WGA- and Con-A-Sepharose establishes the glycoproteinic 
nature of the 5HT-reuptake system. A serious limitation of 
WGA chromatography as a prefractionation step is the low 
capacity of the resin when starting with a membrane solu- 
bilizate. A potential way to overcome this handicap involves 
the use of a DEAE ion-exchange chromatography step prior 
to WGA chromatography. Application of membrane solu- 
bilizate, dialyzed against 10 mM KPi buffer containing 10 mM 
NaCI, 2 mM MgCI,, 1 mM EDTA, 0.3 mM DTT, and 0.1 
mM PMSF, to a DE-52 cellulose column followed by an 
elution step using a gradient from 10 to 300 mM NaCl in the 
above buffer containing 0.1 % digitonin gave a satisfactory 64 
f 7% recovery of binding activity at 50-100 mM NaCl (n = 
6). However, the overall yield of the three-step purification 
procedure involving DEAE-, WGA-, and AMC-Affi-Gel 
chromatography was too low to allow recovery of significant 
binding activity in the last step. 
The rationale for the elution procedure of the AMC affinity 
column is as follows. The column was washed with loading 
buffer followed by the same buffer containing 20% ethylene 
glycol to elute nonspecifically bound hydrophobic proteins. To 
achieve elution of the IBS, a buffer was used containing 10 
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nM citalopram but lacking NaCl. As established, the absence 
of NaCl reduces the affinity of the IBS for imipramine and 
its analogues. However, if this elution buffer was used directly 
after the ethylene glycol containing buffer, a considerable 
amount of contaminating protein eluted along with the imi- 
pramine binding activity. To avoid this, a third elution step 
was introduced-a buffer identical with the specific elution 
buffer but lacking citalopram. Application of affinity chro- 
matography to the prepurified solubilizate resulted in an overall 
purification of 10000-fold at a recovery of 22%. The degree 
of purification was calculated from the receptor density (B-) 
and a rough estimate of the protein content of the partially 
purified fraction from the SDS gel by using the density of the 
'2SI-labeled BSA band as an internal standard. The relatively 
low recovery of the affinity step might originate from a reduced 
stability or from proteolytic degradation of the protein under 
partially purified conditions. The effect of y-globulin, 0.3 
mg/mL, and phospholipids, egg yolk L-a-phosphatidylcholine 
type IX-E (0.3 mg/mL), on the stability during dialysis and 
the AMC-Affi-Gel chromatography step was examined. No 
increased stability was observed. 
Various studies have speculated on a reuptake system 
consisting of distinct, mutually exclusive, regulatory and carrier 
sites within the protein (Sette et al., 1983; Reith et al., 1984; 
Mellerup et al., 1983; Biessen et al., 1988). Viewed in this 
light, an identification of both the carrier site and the IBS 
within the partially purified preparation will be required. An 
appropriate way to verify the intactness of the partially purified 
protein involves the comparison of its pharmacological binding 
profile with that of the membrane-bound 5HT-reuptake sys- 
tem. The binding profile of the partially purified IBS shows 
a significant correlation (0.972 and 0.982, respectively) with 
that of the solubilizate and of the membrane-bound protein. 
This observation indicates that either a copurification of a 
regulatory site and the carrier site has been accomplished or 
that both sites implicate the same protein. 
The labeling intensity of both the 78- and 55-kDa proteins 
on SDS-PAGE corresponded well with the intensity expected 
on the basis of the binding activity. In some experiments, 
specific elution of only the 78-kDa band was observed, sug- 
gesting that the 55-kDa protein might arise from proteolytic 
degradation. 
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ABSTRACT: Human plasma fibronectin, a dimeric glycoprotein, contains two cryptic free sulfhydryl groups 
per chain. Recent observations revealed that upon binding to a gelatin-coated surface the SH, site, located 
between the DNA-binding and cell-binding domains, is partially exposed, while the SH2 site, situated within 
the carboxyl-terminal fibrin-binding domain, remains buried. Utilizing this newly discovered property of 
plasma fibronectin, we have developed a procedure to introduce maleimide derivatives of fluorescent probes 
such as N-( 1 -pyrenyl)maleimide, 7-(diethylamino)-3-(4’-maleimidylphenyl)-4-methylcoumarin, or fluorescein 
5-maleimide selectively into either the SH, or SH2 site of the fibronectin molecule and have measured the 
inter-sulfhydryl distances in fibronectin by fluorescence energy transfer methods. The results show that 
the distance between the SHI site of one subunit and the SH, site of the other subunit is between 35 and 
44 A, indicating the close proximity of the two subunits near the SH1-containing regions. On the other 
hand, the distance between the SH2 site of one subunit and the SH2 site of the other subunit is found to 
be greater than 95 A, suggesting that the two SH2-containing regions are well separated. Additionally, 
the distance between the SH1 and SH2 sites within each subunit is estimated to be 42-53 8, assuming no 
intersubunit energy transfer between the probes. Heparin or high salt, which drastically affects the hy- 
drodynamic properties of fibronectin, had virtually no effect on the distance between the SH1-SHI or the 
SHl-SH2 pair. In contrast, upon adsorption of the protein to Cytodex microcarriers, the energy transfer 
between the SHI sites was markedly reduced, implying a surface-mediated separation of the two subunits 
of fibronectin. 
F. ibronectin (Fn) is a large glycoprotein present in blood 
plasma and other body fluids and in tissues. It plays a part 
in numerous biological phenomena including cell adhesion and 
spreading, wound healing, phagocytosis, and differentiation 
[see Akiyama and Yamada (1987), McDonagh (1985), and 
Mosher (1 984) for reviews]. The protein contains two nearly 
identical subunits of 240-250 kDa each, linked near their 
carboxyl termini by two disulfides. Within each subunit are 
several distinct structural domains that can be isolated from 
proteolytic digests with retention of specific binding affinities 
toward a host of macromolecules including fibrin, heparin, 
collagen, DNA, and cell surface molecules. Relatively little 
is known concerning the spatial arrangement of these structural 
domains of this complex protein. 
Fn contains two free sulfhydryl groups per subunit: one 
located in a type 111 homology region between the DNA- 
binding and cell-binding domains (designated SHI )  (Skor- 
stengaard et al., 1986) and the other also located in a type 111 
homology region but within the carboxyl-terminal fibrin- 
binding domain (designated SH2) (Garcia-Pardo et al., 1985). 
Neither of these sulfhydryl groups is accessible to sulfhydryl 
reagents in the absence of chaotropic agents (Smith et al., 
1982; Lai & Tooney, 1984). Recently, we have shown that 
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upon adsorption of Fn to a gelatin-coated surface the SHI  site 
is partially exposed, while the SH2 site remains buried 
(Narasimhan & Lai, 1989b). Here we have used this new 
observation to develop a procedure that allows the differential 
labeling of either SH, or SH, in Fn with maleimide derivatives 
of fluorescent probes (see Figure 1) and have measured in- 
ter-sulfhydryl distances of Fn by fluorescence energy transfer 
methods (Lakowicz, 1983; Stryer, 1978). 
MATERIALS AND METHODS 
Fn was purified from fresh-frozen human plasma, obtained 
from the Blood Center of Southeastern Wisconsin, on a ge- 
latin-Sepharose 4B affinity column (Engvall & Ruoslahti, 
1977). The integrity and purity of the protein, before and after 
labeling with the sulfhydryl reagents, were routinely examined 
with sodium dodecyl sulfatepolyacrylamide gel electrophoresis 
(SDS-PAGE). The fluorescence probes N-( 1 -pyrenyl)male- 
imide (P), 7-(diethylamino)-3-(4’-maleimidylphenyl)-4- 
methylcoumarin (C), and fluorescein 5-maleimide (F) were 
purchased from Molecular Probes (Eugene, OR). Polystyrene 
latex beads with surface carboxyl groups were purchased from 
Polysciences (Warrington, PA). The beads used in this study 
had a diameter of 0.5 pm. Tris(hydroxymethy1)aminomethane 
(Tris), phenylmethanesulfonyl fluoride (PMSF), 1-[3-(di- 
methylamino)propyl]-3-ethylcarbodiimide hydrochloride 
(carbodiimide), trypsin (bovine pancreas), and heparin (porcine 
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